Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Boris Gershman, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kim SP, Karnes RJ, Mwangi R, Van Houten H, Gross CP, Gershman B, Leapman MS, Shah ND. Contemporary Trends in Magnetic Resonance Imaging at the Time of Prostate Biopsy: Results from a Large Private Insurance Database. Eur Urol Focus. 2019 Apr 29. PMID: 31047904.
    Citations:    
  2. Gershman B, Leibovich BC, Kim SP. Partial Versus Radical Nephrectomy for the Clinical T1a Renal Mass. Eur Urol Focus. 2019 Feb 15. PMID: 30777722.
    Citations:    
  3. Gershman B, Maroni P, Tilburt JC, Volk RJ, Konety B, Bennett CL, Kutikov A, Smaldone MC, Chen V, Kim SP. A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer. World J Urol. 2019 Jan 22. PMID: 30671637.
    Citations:    
  4. Brito J, Golijanin B, Kott O, Moshnikova A, Mueller-Leonhard C, Gershman B, Andreev OA, Reshetnyak YK, Amin A, Golijanin D. Ex-vivo Imaging of Upper Tract Urothelial Carcinoma Using Novel ICG-Var3 pHLIP Imaging Agent. Urology. 2019 Jan 16. PMID: 30659902.
    Citations:    
  5. Linder BJ, Gershman B, Bews KA, Glasgow AE, Occhino JA. A National Contemporary Analysis of Perioperative Outcomes for Vaginal Vault Prolapse: Minimally invasive Sacrocolpopexy Versus Nonmesh Vaginal Surgery. Female Pelvic Med Reconstr Surg. 2019 Jan 09. PMID: 30628947.
    Citations:    
  6. Pereira JF, Pareek G, Mueller-Leonhard C, Zhang Z, Amin A, Mega A, Tucci C, Golijanin D, Gershman B. The Perioperative Morbidity of Transurethral Resection of Bladder Tumor: Implications for Quality Improvement. Urology. 2019 03; 125:131-137. PMID: 30366045.
    Citations:    
  7. Gershman B, Bukavina L, Chen Z, Konety B, Schumache F, Li L, Kutikov A, Smaldone M, Abouassaly R, Kim SP. The Association of Robot-assisted Versus Pure Laparoscopic Radical Nephrectomy with Perioperative Outcomes and Hospital Costs. Eur Urol Focus. 2018 Oct 22. PMID: 30361146.
    Citations:    
  8. Gershman B, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma. Eur Urol. 2018 12; 74(6):825-832. PMID: 30262341.
    Citations:    
  9. Lyon TD, Gershman B, Shah PH, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era. Urol Oncol. 2018 11; 36(11):499.e1-499.e7. PMID: 30228096.
    Citations:    
  10. Brito J, Pereira J, Moreira DM, Pareek G, Tucci C, Guo R, Zhang Z, Amin A, Mega A, Renzulli J, Golijanin D, Gershman B. The association of lymph node dissection with 30-day perioperative morbidity among men undergoing minimally invasive radical prostatectomy: analysis of the National Surgical Quality Improvement Program (NSQIP). Prostate Cancer Prostatic Dis. 2018 06; 21(2):245-251. PMID: 29858588.
    Citations:    
  11. Gershman B, Guo DP, Dahabreh IJ. Using observational data for personalized medicine when clinical trial evidence is limited. Fertil Steril. 2018 06; 109(6):946-951. PMID: 29935652.
    Citations:    
  12. Linder BJ, Occhino JA, Habermann EB, Glasgow AE, Bews KA, Gershman B. A National Contemporary Analysis of Perioperative Outcomes of Open versus Minimally Invasive Sacrocolpopexy. J Urol. 2018 10; 200(4):862-867. PMID: 29630983.
    Citations:    
  13. Bhindi B, Wallis CJD, Boorjian SA, Thompson RH, Farrell A, Kim SP, Karam JA, Capitanio U, Golijanin D, Leibovich BC, Gershman B. The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis. BJU Int. 2018 05; 121(5):684-698. PMID: 29319926.
    Citations:    
  14. Pereira J, Renzulli J, Pareek G, Moreira D, Guo R, Zhang Z, Amin A, Mega A, Golijanin D, Gershman B. Perioperative Morbidity of Open Versus Minimally Invasive Partial Nephrectomy: A Contemporary Analysis of the National Surgical Quality Improvement Program. J Endourol. 2018 02; 32(2):116-123. PMID: 29121786.
    Citations:    
  15. Gershman B, Thompson RH, Boorjian SA, Larcher A, Capitanio U, Montorsi F, Carenzi C, Bertini R, Briganti A, Lohse CM, Cheville JC, Leibovich BC. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis. J Urol. 2018 05; 199(5):1143-1148. PMID: 29225056.
    Citations:    
  16. Gershman B, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Perioperative Morbidity of Lymph Node Dissection for Renal Cell Carcinoma: A Propensity Score-based Analysis. Eur Urol. 2017 Nov 10. PMID: 29132713.
    Citations:    
  17. Brito J, Gershman B. The role of lymph node dissection in the contemporary management of renal cell carcinoma: A critical appraisal of the evidence. Urol Oncol. 2017 11; 35(11):623-626. PMID: 28712789.
    Citations:    
  18. Haddad AQ, Hutchinson R, Wood EL, Miranda G, Gershman B, Messer J, Svatek R, Black PC, Boorjian SA, Shah J, Daneshmand S, Lotan Y. Association of Distance to Treatment Facility With Survival and Quality Outcomes After Radical Cystectomy: A Multi-Institutional Study. Clin Genitourin Cancer. 2017 12; 15(6):689-695.e2. PMID: 28558988.
    Citations:    
  19. Gershman B, Meier SK, Jeffery MM, Moreira DM, Tollefson MK, Kim SP, Karnes RJ, Shah ND. Redefining and Contextualizing the Hospital Volume-Outcome Relationship for Robot-Assisted Radical Prostatectomy: Implications for Centralization of Care. J Urol. 2017 07; 198(1):92-99. PMID: 28153509.
    Citations:    
  20. Gershman B, Van Houten HK, Herrin J, Moreira DM, Kim SP, Shah ND, Karnes RJ. Corrigendum re: "Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications" [Eur Urol 2017;71:55-65]. Eur Urol. 2017 05; 71(5):e160. PMID: 28118942.
    Citations:    
  21. Gershman B, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection. Eur Urol. 2017 08; 72(2):300-306. PMID: 28094055.
    Citations:    
  22. Gershman B, Thompson RH, Moreira DM, Boorjian SA, Tollefson MK, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis. Eur Urol. 2017 04; 71(4):560-567. PMID: 27671144.
    Citations:    
  23. Gershman B, Thompson RH, Moreira DM, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based Analysis. J Urol. 2017 03; 197(3 Pt 1):574-579. PMID: 27663461.
    Citations:    
  24. Gershman B, Boorjian SA. Primum Non Nocere: Critically Assessing the Morbidity of Prostate Biopsy. Eur Urol. 2017 03; 71(3):366-367. PMID: 27614695.
    Citations:    
  25. Zaid HB, Parker WP, Safdar NS, Gershman B, Erwin PJ, Murad MH, Boorjian SA, Costello BA, Thompson RH, Leibovich BC. Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. J Urol. 2017 01; 197(1):44-49. PMID: 27473875.
    Citations:    
  26. Gershman B, Van Houten HK, Herrin J, Moreira DM, Kim SP, Shah ND, Karnes RJ. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications. Eur Urol. 2017 01; 71(1):55-65. PMID: 26995328.
    Citations:    
  27. Moreira DM, Gershman B, Lohse CM, Boorjian SA, Cheville JC, Leibovich BC, Thompson RH. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy. World J Urol. 2016 Oct; 34(10):1465-72. PMID: 26914818.
    Citations:    
  28. Gershman B, Takahashi N, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model. BJU Int. 2016 Nov; 118(5):742-749. PMID: 26800148.
    Citations:    
  29. Gershman B, Leibovich BC. Assessing the Evidence for the Surgical Management of Renal Cell Carcinoma with Venous Tumor Thrombus: Room to Grow. Eur Urol. 2016 08; 70(2):281-2. PMID: 26755340.
    Citations:    Fields:    Translation:HumansCells
  30. Bernard B, Gershman B, Karnes RJ, Sweeney CJ, Vapiwala N. Approach to Oligometastatic Prostate Cancer. Am Soc Clin Oncol Educ Book. 2016; 35:119-29. PMID: 27249693.
    Citations: 3     Fields:    Translation:Humans
  31. Westerman ME, Gershman B, Karnes RJ, Thompson RH, Rangel L, Boorjian SA. Impact of a family history of prostate cancer on clinicopathologic outcomes and survival following radical prostatectomy. World J Urol. 2016 Aug; 34(8):1115-22. PMID: 26658661.
    Citations:    Fields:    Translation:Humans
  32. Moreira DM, Friedlander JI, Hartman C, Gershman B, Smith AD, Okeke Z. Association of estimated glomerular filtration rate with 24-h urinalysis and stone composition. Urolithiasis. 2016 Aug; 44(4):319-25. PMID: 26573808.
    Citations:    Fields:    Translation:Humans
  33. Chew BH, Flannigan R, Kurtz M, Gershman B, Arsovska O, Paterson RF, Eisner BH, Lange D. A Single Dose of Intraoperative Antibiotics Is Sufficient to Prevent Urinary Tract Infection During Ureteroscopy. J Endourol. 2016 Jan; 30(1):63-8. PMID: 26413885.
    Citations: 3     Fields:    Translation:Humans
  34. Moreira DM, Gershman B, Rangel LJ, Boorjian SA, Thompson RH, Frank I, Tollefson MK, Gettman MT, Karnes RJ. Evaluation of pT0 prostate cancer in patients undergoing radical prostatectomy. BJU Int. 2016 Sep; 118(3):379-83. PMID: 26305996.
    Citations:    
  35. Gershman B, Boorjian SA, Hautmann RE. Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know? Bladder Cancer. 2015 Sep 05; 2(1):1-14. PMID: 27376120.
    Citations:    
  36. Gershman B, Karnes RJ. Re: comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. Eur Urol. 2015 Sep; 68(3):536-7. PMID: 26282353.
    Citations:    Fields:    Translation:Humans
  37. Gershman B, Moreira DM, Tollefson MK, Frank I, Cheville JC, Thapa P, Tarrell RF, Thompson RH, Boorjian SA. The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Urol Oncol. 2016 Jan; 34(1):4.e1-9. PMID: 26329815.
    Citations: 4     Fields:    Translation:Humans
  38. Moreira DM, Gershman B, Thompson RH, Okuno SH, Robinson SI, Leibovich BC, Boorjian SA. Clinicopathologic characteristics and survival for adult renal sarcoma: A population-based study. Urol Oncol. 2015 Dec; 33(12):505.e15-20. PMID: 26321056.
    Citations:    Fields:    Translation:Humans
  39. Gershman B, Psutka SP, McGovern FJ, Dahl DM, Tabatabaei S, Gettman MT, Frank I, Carlson RE, Rangel LJ, Barry MJ, Blute ML, Karnes RJ. Patient-reported Functional Outcomes Following Open, Laparoscopic, and Robotic Assisted Radical Prostatectomy Performed by High-volume Surgeons at High-volume Hospitals. Eur Urol Focus. 2016 Jun; 2(2):172-179. PMID: 28723533.
    Citations: 1     Fields:    
  40. Gershman B, Karnes RJ. Screening for Prostate Cancer: Current Status and Future Directions. Eur Urol Focus. 2015 Sep; 1(2):147-148. PMID: 28723425.
    Citations:    
  41. Gershman B, Moreira DM, Boorjian SA, Lohse CM, Cheville JC, Costello BA, Leibovich BC, Thompson RH. Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy. Eur Urol. 2016 Jan; 69(1):84-91. PMID: 26044802.
    Citations: 8     Fields:    Translation:Humans
  42. Gershman B, Eisenberg MS, Thompson RH, Frank I, Kaushik D, Tarrell R, Thapa P, Boorjian SA. Comparative impact of continent and incontinent urinary diversion on long-term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a. Int J Urol. 2015 Jul; 22(7):651-6. PMID: 25881721.
    Citations: 3     Fields:    Translation:Humans
  43. Barrisford GW, Gershman B, Blute ML. The role of lymphadenectomy in the management of renal cell carcinoma. World J Urol. 2014 Jun; 32(3):643-9. PMID: 24723269.
    Citations: 4     Fields:    Translation:Humans
  44. Gershman B, Eisner BH, Sheth S, Sacco DE. Ureteral stenting and retrograde pyelography in the office: clinical outcomes, cost effectiveness, and time savings. J Endourol. 2013 May; 27(5):662-6. PMID: 23638674.
    Citations:    Fields:    Translation:Humans
  45. Sterious S, Simhan J, Uzzo RG, Gershman B, Li T, Devarajan K, Canter D, Walton J, Fogg R, Ginzburg S, Corcoran A, Smaldone MC, Kutikov A. Familiarity and self-reported compliance with American Urological Association best practice recommendations for use of thromboembolic prophylaxis among American Urological Association members. J Urol. 2013 Sep; 190(3):992-8. PMID: 23538239.
    Citations: 9     Fields:    Translation:Humans
  46. Gershman B, Shui IM, Stampfer M, Platz EA, Gann PH, Sesso HL, DuPre N, Giovannucci E, Mucci LA. Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer. Eur Urol. 2014 Apr; 65(4):683-9. PMID: 23340241.
    Citations: 10     Fields:    Translation:Humans
  47. Gershman B, Sheth S, Dretler SP, Herrick B, Lang K, Pais VM, Eisner BH. Relationship between glomerular filtration rate and 24-hour urine composition in patients with nephrolithiasis. Urology. 2012 Jul; 80(1):38-42. PMID: 22608801.
    Citations: 5     Fields:    Translation:Humans
  48. Gershman B, Eisner BH. Editorial comment. Urology. 2012 May; 79(5):994-5. PMID: 22309785.
    Citations:    Fields:    Translation:Humans
  49. Gershman B, Zietman AL, Feldman AS, McDougal WS. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies. Urol Oncol. 2013 Oct; 31(7):1093-7. PMID: 22305626.
    Citations: 9     Fields:    Translation:Humans
  50. Gershman B, Eisner BH. Editorial comment. Urology. 2012 Jan; 79(1):92-3; author reply 93-4. PMID: 22202545.
    Citations:    Fields:    Translation:Humans
  51. Gershman B, Dahl DM, Olumi AF, Young RH, McDougal WS, Wu CL. Smaller prostate gland size and older age predict Gleason score upgrading. Urol Oncol. 2013 Oct; 31(7):1033-7. PMID: 22206627.
    Citations: 8     Fields:    Translation:Humans
  52. Gershman B, Kulkarni N, Sahani DV, Eisner BH. Causes of renal forniceal rupture. BJU Int. 2011 Dec; 108(11):1909-11; discussion 1912. PMID: 21736690.
    Citations: 20     Fields:    Translation:Humans
  53. Chew BH, Paterson RF, Ferlic EA, Humphreys MR, Gershman B, Eisner BH. Case presentation. J Endourol. 2011 Jul; 25(7):1105-9. PMID: 21711133.
    Citations:    Fields:    Translation:HumansCells
  54. Kutikov A, Vanarsdalen KN, Gershman B, Fossett LK, Guzzo TJ, Wein AJ, Malkowicz SB. Enucleation of renal cell carcinoma with ablation of the tumour base. BJU Int. 2008 Sep; 102(6):688-91. PMID: 18384627.
    Citations: 5     Fields:    Translation:Humans
  55. Gershman B, Puig O, Hang L, Peitzsch RM, Tatar M, Garofalo RS. High-resolution dynamics of the transcriptional response to nutrition in Drosophila: a key role for dFOXO. Physiol Genomics. 2007 Mar 14; 29(1):24-34. PMID: 17090700.
    Citations: 69     Fields:    Translation:AnimalsCells
  56. Hwangbo DS, Gershman B, Gersham B, Tu MP, Palmer M, Tatar M. Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature. 2004 Jun 03; 429(6991):562-6. PMID: 15175753.
    Citations: 278     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Gershman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (181)
Explore
_
Co-Authors (20)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.